Finding the Balance between Clinical & Commercial Key Roles. Stewart Geary Chief Medical Officer, Senior Vice President, Eisai, Japan

Transcription

1 IBC LIFE SCIENCES Part of: 4 TH ANNUAL Grand Copthorne Waterfront Hotel, Finding the Balance between Clinical & Commercial Key Roles Expert Faculty Include: Ajay Tiku Vice President Medical, Asia Pacific, North & South Asia, GlaxoSmithKline, Jeonghoon Han Regional Medical Director, APAC, Teva Pharmaceuticals, Dr Abhishek Bhagat Head, Medical Science & Regional Medical Director, Consumer Health Asia, Merck Group, Stewart Geary Chief Medical Officer, Senior Vice President, Eisai, Japan Prabhuram Krishnan Medical Director, Eli Lilly and Company, Manish Garg Medical Director, MSD Pharmaceuticals, Pertinent Issues Covered: Understanding the true role of Medical affairs and its evolving trends from therapeutic roles to developing business-oriented medical strategies Exclusive tips on how to collaborate effectively with marketing, sales, regulatory and clinical personnel in a cross functional team Gain insights into a sustained successful KOL management and engagement strategies Benchmark with experts to find out best practices employed in their companies Medical affairs teams and training of their Medical Science Liasons (MSLs) Effectively measure the performance of your medical affairs team and successfully hit your KPIs Co-located with: ACCESS2015 Produced by: Supported by: Media Partners: Life Sciences International Marketing Partner:

2 4TH ANNUAL Thursday 8:50 Welcome Address by IBC Asia 9:00 Chairman s Opening Remarks Timothy Low, Vice President, Medical Affairs APAC, Medtronic, Engaging Effectively with Stakeholders for Maximum Success 9:10 Overcoming Challenges in a Cross Functional Team & Meeting Expectations of All Stakeholders Communicate and coordinate field team value with internal stakeholders Linking synergies and reconciling differences in a cross functional team Understanding the right competencies that support cross functional teams of therapeutic expertise, sales and marketing, regulatory, R&D, legal,compliance etc. Maintaining the balance between MA as a commercial role versus its role in Therapeutics Where are the biggest opportunities for medical affairs professionals? How do we approach common challenges faced in the region? Where should be the biggest investment to improve efficiencies? Ajay Tiku, Vice President Medical, Asia Pacific, North & South Asia, GlaxoSmithKline, Stewart Geary, Chief Medical Officer, Senior Vice President, Eisai, Japan Victoria Elegant, Vice President, Medical & Regulatory Affairs, Baxter China PANEL DISCUSSION Leveraging Medical Affairs for Commercial Success 9:50 Develop a Medical Strategy that Aligns with Business Goals Coordinating medical strategy with the overall business strategy to maximize overall success Tools and templates to be created for strategic planning processes Determine the type of support foundation needed to effectively run medical field teams Develop a roadmap to properly allocate resources and to heighten the team s understanding of the strategic processes Jeonghoon Han, Regional Medical Director, APAC, Teva Pharmaceuticals, 10:30 Morning Networking and Refreshment Break 11:00 Creating Synergies between Marketing & Medical Affairs Managing different priorities and expectations between Medical Affairs and Marketing What are the common areas of potential conflict between medical affairs and the marketing team? What medical affairs teams are looking for in aligning marketing campaigns with business goals Best practices in internal and external communication to address the correct needs of patients and prescribers Medical affairs input for the success of commercial strategies: Collaboration for a win-win situation Sivabalan Sivanesan, Medical and Regulatory Affairs Director, Roche Malaysia Effective KOL Engagement and Successful Partnerships 11:40 Strategic KOL Engagement and Management Developing a sustained KOL management program across the product life cycle Reviewing recent trends and creative ways to engage KOL Ensuring smooth communication and work relationships with KOLs Features of a good industry-kol partnership Optimizing KOL engagements through networking and value exchanges Aligning KOL s expectations with Medical Affairs Dr Timothy Low, Vice President, Medical Affairs APAC, Medtronic, Manish Garg, Medical Director, MSD Pharmaceuticals, Prabhuram Krishnan, Medical Director, Eli Lilly and Company, PANEL DISCUSSION 12:20 Networking Luncheon Medical Affairs Integral Role in Clinical Development 1:30 Clinical Development and Medical Affairs: Realizing Synergies for Successful Drugs Improving efficacy of clinical development and medical affair strategies Real world evidence generation for Medical Affairs to meet increasing demands of regulatory agencies Identifying unmet medical needs and develop integrated strategies to address these needs Being innovative Innovative patients access/assistance programs Finding the balance between therapeutic, scientific role versus commercial role in Medical affairs Clinical development resource planning- using synergies between development and medical affairs Effective product life-cycle management strategy Victoria Elegant, Vice President, Medical, Clinical & Regulatory Affairs, Baxter China 2:10 Effective Management of Observational Studies and Investigator- Initiated Studies (IIS) Review considerations regarding supporting investigator-initiated trials and the impact on funding, compliance and resources Strategies for successful IITs & how IITs benefit doctors Issues related to transparency in research funding and the needs of researchers as well as Medical Affairs organizations Stewart Geary, Chief Medical Officer, Senior Vice President, Eisai, Japan Optimize the Impact of a High-Performing Medical Affairs Team 2:50 High Performing Medical Science Liaisons Teams and Key Success Factors Understand the core competencies of top-performing MSL teams Managing KOL Relationship - Maintaining objectivity and reviewing success factors to building sustainable relationships Develop MSL value propositions that deliver their organizations needs Ajay Tiku, Vice President Medical, Asia Pacific, North & South Asia, GlaxoSmithKline, 3:30 Afternoon Refreshments 4:00 Addressing Success Factors and Hitting the KPI in Medical Affairs What are the key indicators of success in medical affairs? Get a deeper understanding of what medical affairs directors find important and relevant to evaluate Analyze the perceived and relevant value in KOL interactions Understand metrics data and how it relates to the medical field team function Dr Abhishek Bhagat, Head, Medical Science & Regional Medical Director, Consumer Health Asia, Merck Group, Managing Resource Constraints and Innovative Programs 4:40 Resource Allocation & Implementing an Effective Talent Development Program Resource allocation with limited budget: How to prioritize your medical affairs activities? Dealing with the lack of skilled talent and manpower Equipping and grooming newcomers with all-rounded skills Orienting them towards cross functional collboration Prabhuram Krishnan, Medical Director, Eli Lilly and Company, 5:20 Early Access Program (EAP) for Patients Oncology Resourcing and expertise for EAP Preparing the organization for establishing an ethical and compliant EAP Driving access to patients with unmet medical need by operationalizing an EAP Overcoming challenges in EAP Manish Garg, Medical Director, MSD Pharmaceuticals, 6:00 Chairperson s Closing Remarks & End of Forum

3 4TH ANNUAL Thursday Medical Affairs has evolved from a supportive role into becoming a central function to ensure success in their organisations. Medical Affairs teams need to collaborate with Clinical, Marketing and Regulatory Affairs teams and thus, play a multi -functional and integral role in science, regulatory and commercial affairs. They need to constantly keep up to date with issues and think strategically to ensure continuous success in their organisations. This forum is the must attend event for those senior decision-makers looking to drive their medical affairs teams and clinical departments and enhance their KOL and stakeholder engagement at all levels. Who Should Attend: INDUSTRIES Pharma/biotech 68% Medical Devices 15% CROs 10% Consultancies 5% Medical Affairs Sourcing 2% Why You Must Attend This Year s Event Hear from experienced Medical Affairs Directors on building a successful Medical Affairs team and operations in Asia Network with industry thought leaders and peers from global pharma and medical device companies operating in the region Benchmark your current strategies against industry best practices Develop strategies to gain market access into key Asian markets This 2015 conference will examine the following pertinent and key issues: Improving Communication and Establish Sustained Partnerships with KOLs in Key Therapeutic Areas Engaging Effectively with Internal Stakeholders for Maximum Success Developing a Medical Strategy that Aligns with Business Goals and Synergies with Marketing Clinical Development and Medical Affairs: Realizing Synergies for Successful Drugs Effective Management of Observational Studies and Investigator-Initiated Studies (IIS) Understanding the Legal and Compliance Landscape for Medical Affairs High Performing Medical Science Liaisons Teams and Key Success Factors Addressing Success Factors and Hitting the KPI in Medical Affairs Effective Planning and Execution under Resource Constraints Developing Extensive Talent Development Training Programs GEOGRAPHIES South East Asia 60% Malaysia 15% Rest of SEA 5% North Asia China/Taiwan 10% Korea/Japan 5% Europe 3% USA 1% Rest of the World 1% 4 Events Under 1 Roof ACCESS2015 4TH ANNUAL Why You Should Sponsor PharmaCon Position your company as a market leader at this event and our customized Sponsorship & Exhibition package offers prime exposure to key decision-makers and exceptional branding. To explore the range of thought leadership, speaking, branding and marketing opportunities available, please contact Yvonne Leong at or yvonne.leong@ibcasia.com.sg

4 3 - What is PharmaCon? The Pharmaceutical Congress Asia (PharmaCon) is the leading annual event that brings together Government, pharmaceutical companies, CROs and suppliers in Asia across: 3 Conferences 2 Forums 4 Workshops 4 Days of Value-Packed Information Hours of networking opportunities The dynamic program and networking platform aims to enable companies to develop strong partnerships, to drive innovation and growth, as well as winning products and services, in Asia s growing pharmaceutical industry. Programme at a Glance Pre-Conference Special Forum 3 August 2015 Leadership in Clinical Trials Pre-Conference Workshops 3 August 2015 Main Conference Day One 4 August 2015 PharmaCon Registration Opens Morning Coffee & Grand Opening of the Shared Networking & Exhibition Area Welcome From IBC Asia & Speed Networking Visionary Keynote Sessions Asia s Healthcare Reform Pharmaceutical Market and Investment Opportunities Morning Networking & Refreshment break ACCESS2015 Clinical Trial Market Opportunities in Asia-Pacific Regulatory Updates: Latest Country-Focused Updates Asia Pharma Market Investment & Expansion Opportunities Networking Lunch & Meet the Pharma VIP Experts Round Table Discussions Round Table Discussions Round Table Discussions End of Conference Day One Main Conference Day Two 5 August 2015 ACCESS2015 Partnerships & Outsourcing Strategies Good Clinical Practice & Compliance Identifying Regulatory Pathways & Crafting Regulatory Strategies for Key Products Morning Networking & Refreshment break Real World Evidence & Health Economics Outcome Research Pricing & Reimbursement Efficient & Cost-Effective Trial Operations in Asia Regulatory Considerations for Clinical Out-Licensing & Partnerships Development & NDA Networking Lunch & Meet the Pharma VIP Experts Modernizing & Transforming Clinical Practices in Asia Achieving Operational Excellence in Delivering Dossier Submissions Post- Market Surveillance Essentials & Compliance End of PharmaCon 2015 Post-Conference Special Forum Preparing for New Product Launches & Successfully Bringing Products to Market Pharmaceutical Compliance: Lessons for the Industry 4TH ANNUAL Post-Conference Workshop

5 IBC LIFE SCIENCES 4 Successful Events in 1 Location 3-6 AUGUST 2015 SINGAPORE 3 - Grand Copthorne Waterfront Hotel, Asia s premier Clinical Trials conference is designed for professionals in the clinical trial value chain to find out the latest investment, partnership and collaboration opportunities, challenges facing drug discovery and clinical development and strategies to improve clinical operations and productivity in Asia. Senior level professionals from Pharmaceutical R&D Drug Discovery Clinical Trial and Development Clinical Project Management & Operations Contract Research & Outsourcing Chief Medical Officers & Directors Clinical Regulatory Affairs & Medical Affairs Designed for regulatory professionals in the pharmaceutical industry to come together to discuss effective regulatory strategies for product access into Asia and also globally as well as to gain clarity on the complex and ever changing regulations in the region. Professionals dealing with: Global/Regional Regulatory Affairs Regulatory Compliance Regulatory Submissions & Publishing Pharmacovigilance Market Access ACCESS2015 Designed for regional and country managers and senior executives from marketing, commercial development, Government affairs and business development, the conference pinpoints key success factors in strategizing market entry in Asia s complex diverse, competitive and growing pharmaceutical market. This event is Asia s one and only platform to provide updated and in-depth evaluation on profitable and successful market entries. CEO Head of Health Economics President/Managing Head of Business Director/Vice President of Asia Development Country Manager Head of Commercial Regional Marketing Director Head of Product Head of Corporate Planning Development Head of Government Affairs Head of Procurement & Head of Marketing & Sales Sourcing Head of Market Access & Head of Compliance Pricing 4 TH ANNUAL MEDICAL AFFAIRS FORUM ASIA is the region s longest running medical affairs forum where best practices are shared and common issues with like-minded peers are discussed. This event will bring insights on how to be more effective in enhancing your company s scientific reputation and communicating the value of your products. Chief Medical Officers Medical Affairs Directors Medical Affairs Managers MSLs and KOLs Medical and Scientific Affairs Executives